Stock SLRX SALARIUS PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Salarius Pharmaceuticals, Inc.

Equities

SLRX

US79400X4043

Market Closed - Nasdaq
Other stock markets
 04:30:01 2024-07-05 pm EDT 		5-day change 1st Jan Change
2.275 USD -5.99% Intraday chart for Salarius Pharmaceuticals, Inc. -4.41% -56.25%
Jun. 17 Clinical Data on Salarius Pharmaceuticals? Seclidemstat in Patients with Mds and Cmml Presented At the 2024 European Hematology Association Annual Meeting CI
May. 13 Salarius Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Salarius Pharmaceuticals Appoints Daniela Santiesteban, Ph.D., to Director of Targeted Protein Degradation Program
CI
Salarius Pharmaceuticals, Inc. Names Nadeem Mirza as Senior Vice President Clinical Development
CI
Salarius Pharmaceuticals, Inc. Announces Senior Leadership Changes
CI
Salarius Pharmaceuticals, Inc. Announces Executive and Board Changes
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SLRX Stock
  4. News Salarius Pharmaceuticals, Inc.
  5. Insiders